858-692-3573 info@denovicontx.com

Better Drugs to Market Faster

At Denovicon Therapeutics, our goal is to accelerate and improve the development of small-molecule therapeutics by utilizing our decades’ worth of drug discovery expertise, proven computational platform, state-of-the-art hardware infrastructure, and proprietary AI–molecular modeling (hybrid) algorithm. We are currently focused on small-molecule therapies for oncology and immuno-oncology targets.

News

Our Commitment to COVID-19

Denovicon Partners with Scientist.com to Accelerate & Improve the Drug Discovery Process

Denovicon Raises Seed Round

Denovicon Completes Initial Benchmark of Proprietary AI-Molecular Modeling Platform